series-a
Stage
1
Investors
About
Navigator Medicines is a clinical-stage biotech company developing bispecific antibodies to treat inflammatory disorders and autoimmune diseases, with a focus on targeting OX40L and TNFα pathways.
Explore Navigator Medicines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.